PPT-Global Portfolio of Antimalarial Medicines

Translational Product development Access Advanced Nonclinical Patient confirmatory ApprovedERP Human volunteers Patient exploratory Regulatory review MMV048 Artefenomel Ferroquine Sanofi. Ezenduka Charles. 1. , . Okonta. Mathew. 2. , . Ekwunife. Obinna. 2. Health Policy Research Group Department of Pharmacology & Therapeutics, College of Medicine, University of Nigeria Enugu Campus. for asthma. WHO . Technical. Briefing . Seminar. on Essential . Medicines. & Health . Products. , Nov. 2013. Christophe Perrin, . Pharmacist. , MPH – IUATLD (The Union). Asthma. . - Global . Presented By:. . Payal. . Mondal. . Priyadarshini. . K.. . Prachi. . Gaikwad. . Pratik. . Gada. . for asthma. WHO . Technical. Briefing . Seminar. on Essential . Medicines. & Health . Products. , Nov. 2013. Christophe Perrin, . Pharmacist. , MPH – IUATLD (The Union). Asthma. . - Global . Lisa Hedman. June. . 2016. At the 69. th. World Health Assembly in May 2016, . Member States proposed and accepted two resolutions related to shortages of medicines:. Promoting . innovation and access to quality, safe, efficacious and affordable medicines for . Access to medicines and technologies. Report . to the WHA 69. th. . on. . “Addressing the global shortages of medicines and the safety and accessibility of children’s . medication”. . (Doc A69/42. Access to medicines and technologies. Report . to the WHA 69. th. . on. . “Addressing the global shortages of medicines and the safety and accessibility of children’s . medication”. . (Doc A69/42. for asthma. WHO . Technical. Briefing . Seminar. on Essential . Medicines. & Health . Products. , Nov. 2013. Christophe Perrin, . Pharmacist. , MPH – IUATLD (The Union). Asthma. . - Global . Access to medicines and technologies. Report . to the WHA 69. th. . on. . “Addressing the global shortages of medicines and the safety and accessibility of children’s . medication”. . (Doc A69/42. Translational. Product development. Access. Preclinical. Patient confirmatory. Approved/ERP. Human volunteers. Patient exploratory. Regulatory review. MMV048. MMV. Artefenomel. /. Ferroquine. Sanofi. Dr Cécile . Macé. . WHO EMP , Mr Arne-Petter . Sanne. WHO MND, . Mr . Ajuebor. Onyema WHO MND. NCD Programme Managers Seminar. 4 June 2014. Access to NCD essential medicines . on the global agenda. The Horizons Global Uranium Index ETF (“HURA”) is the rst ETF in Canada to provide direct exposure to the global Uranium sector. HURA seeks to replicate, to the extent possible, the p imidazolidinedione. derivatives. Anna . Jaromin. . 1,*. ,. Anna Czopek . 2. ,. Agnieszka . Zagórska. . 2. , Silvia . Parapini. . 3. , Nicoletta . Basilico. . 4. , . Jerzy Gubernator. . 1. 1. Chloroquine (Aralen™) What is chloroquine? Chloroquine (also known as chloroquine phosphate) is an antimalarial medicine. It is available in the United States by prescription only. It is sold